Prognostic significance of serum cholesterol, lathosterol, and sitosterol in old age; A 17-year population study

Annals of Medicine

Volumn 43, Issue 4, 2011, Pages 292-301

  Tilvis, Reijo S ^a   Valvanne, Jaakko N ^b   Strandberg, Timo E ^c   Miettinen, Tatu A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Social and Health Services   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cholesterologenesis; lathosterol; sitosterol; terminal decline

Indexed keywords

ALBUMIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATHOSTEROL; SITOSTEROL; TRIACYLGLYCEROL;

ABSORPTION; AGE; AGED; ALBUMIN BLOOD LEVEL; ANGINA PECTORIS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; COGNITION; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GENDER; GERIATRIC CARE; HEALTH STATUS; HEART INFARCTION; HUMAN; HYPERTENSION; LATHOSTEROL BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SITOSTEROL BLOOD LEVEL; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; BLOOD PRESSURE; BODY MASS INDEX; CAUSE OF DEATH; CHOLESTEROL; COGNITION; FINLAND; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; PEAK EXPIRATORY FLOW RATE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; SITOSTEROLS; SURVIVAL ANALYSIS; VASCULAR DISEASES;

EID: 79957523428     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.546363     Document Type: Article

References (55)

1. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol. 1992;2:161-76.
2. Benfante R, Reed D. Is elevated serum cholesterol a risk factor for coronary heart disease in the elderly. JAMA. 1990;263:393-6. (Pubitemid 20026012)
3. Tervahauta M, Pekkanen J, Nissinen A. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finnish cohorts of the Seven Countries Study. J Am Coll Cardiol. 1995;26:1623-9.
4. Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP Jr, Isaacsohn JL, et al. Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation . 1996;94:2381-8.
5. Casiglia E, Mazza A, Tikhonoff V, Scarpa R, Schiavon L, Pessina AC. Total cholesterol and mortality in the elderly. J Intern Med. 2003;254:353-62. (Pubitemid 37211259)
6. Corti M-C, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB, et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 1995;274: 539-44.
7. Stemmermann GN, Chyou PH, Kagan A, Nomura AM, Yano K. Serum cholesterol and mortality among Japanese-American men. The Honolulu (Hawaii) Heart Program. Arch Intern Med. 1991;151:969-72.
8. Chyou PH, Eaker ED. Serum cholesterol concentrations and all-cause mortality in older people. Age Ageing. 2000;29: 69-74.
9. Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med. 1993;153:1065-73. (Pubitemid 23135464)
10. Krumholz HM, Seeman RE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI, et al. Lack of association between cholesterol and coronary heart disease mortality in persons older than 70 years. JAMA. 1994;272:1335-9.
11. Psaty BM, Anderson M, Kronmal RA, Tracy RP, Orchard T, Fried LP, et al. Association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc. 2004;10:1639-47. (Pubitemid 41709916)
12. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, et al. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation. 1992;86: 1046-60.
13. Iribarren C, Sharp D, Burchfi el CM, Sun P, Dwyer JH. Association of serum total cholesterol with coronary disease and all-cause mortality: Multivariate correction for bias due to measurement error. Am J Epidemiol. 1996; 143:463-71.
14. Menotti A, Kromhout D, Nissinen A, Giampaoli S, Seccareccia F, Feskens E, et al. Short-term all-cause mortality and its determinants in elderly male populations in Finland, The Netherlands, and Italy: the FINE Study. Finland, Italy, Netherlands Elderly Study. Prev Med . 1996;25: 319-26. (Pubitemid 26177575)
15. Curb JD, Abbott RD, Rodriquez BL, Masaki K, Popper J, Chen R, et al. Prospective association between low and high total and low-density lipoprotein cholesterol and coronary heart disease in elderly men. disease in elderly men. J Am Geriatr Soc. 2004;52:1975-80. (Pubitemid 41725011)
16. White AD, Hames CG, Tyroler HA. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study. Ann Epidemiol . 1992;2:85-91.
17. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: A cohort study. Lancet. 2001;358:351-5. (Pubitemid 32739094)
18. Reuben DB, Ix JH, Greendale GA, Seeman TE The predictive value of combined hypoalbuminemia and hypo-cholesterolemia in high functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc. 1999;47:402-6. (Pubitemid 29181363)
19. Forette B, Tortrat D, Wolmark Y. Cholesterol as risk factor for mortality in elderly women. Lancet. 1989;8643:868-70.
20. Weverling-Rijnsburger AWE, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RG. Total cholesterol and risk of mortality in the oldest old. Lancet. 1997;350: 1119-23. (Pubitemid 27454002)
21. Brescianini S, Maggi S, Farchi G, Mariotti S, Di Carlo A, Baldereschi M, et al. Low total cholesterol and increased risk of dying: Are low levels clinical warning signs in the elderly? Results from the Italian Longitudinal Study on Aging. J Am Geriatr Soc. 2003;51:991-6. (Pubitemid 36871148)
22. Onder G, Landi F, Volpato S, Fellin R, Carbonin P, Gambassi G, et al. Serum cholesterol levels and in-hospital mortality in the elderly. Am J Med. 2003;115:265-71. (Pubitemid 37088187)
23. Abbott RD, Ueshima H, Hozawa A, Okamura T, Kadowaki T, Miura K, et al. Risk factor effects and total mortality in older Japanese men in Japan and Hawaii. Ann Epidemiol. 2008;18:913-8.
24. Schupf N, Costa R, Luchsinger J. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatric Soc. 2005,53:219-26. (Pubitemid 41632547)
25. Akerblom JL, Costa R, Luchsinger JA, Manly JJ, Tang MX, Lee JH, et al. Relation to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing. 2008;37: 207-13. (Pubitemid 351445193)
26. Lindroos M, Kupari M, HeikkiläJ, Tilvis R. Prevalance of aortic valve abnormalities in the elderly: an echocar-diographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-5. (Pubitemid 23106200)
27. Tilvis RS, Kähönen-Väre MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59:268-74. (Pubitemid 38375341)
28. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors refl ect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990;131:20-31. (Pubitemid 20014696)
29. Strandberg TE, Salomaa VV, Vanhanen H, Miettinen TA. Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men. Diabetes. 1996;45:755-61. (Pubitemid 26166771)
30. Strandberg TE, Valvanne J, Erkinjuntti T, Sorva A, Tilvis RS. Serum lipids, health, and one-year mortality in randomized age cohorts of 75, 80, and 85 years: the Helsinki Aging Study. Nutr Metab Cardiovasc Dis. 1992;2:101-5.
31. Folstein MF, Folstein SE. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189-98.
32. Hughes CP, Berg L, Danziger WL, Coben LA, Martin R. A new clinical scale for staging of dementia. Br J Psychiatr. 1982;140:566-72. (Pubitemid 12124384)
33. Ehnholm C, Lukka M, Kuusi T, NikkiläE, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res. 1986;27:227-35. (Pubitemid 16097321)
34. Frishman WH, Ooi WL, Derman MP, Eder HA, Gidez LI, Ben-Zeev D, et al. Serum lipids and lipoproteins in advanced age. Intraindividual changes. Ann Epidemiol. 1992;2:43-50.
35. Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation. 1997;96: 37-43.
36. Weijenberg MP, Feskens EJ, Kromhout D. Age-related changes in total and high-density-lipoprotein cholesterol in elderly Dutch men. Am J Public Health. 1996;86:798-803. (Pubitemid 26192015)
37. Abbott RD, Sharp DS, Burchfi el CM, Curb JD, Rodriguez BL, Hakim AA, et al. Cross-sectional and longitudinal changes in total and high-density- lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program. Ann Epidemiol. 1997;7:417-24.
38. Kuzuya M, Ando F, Iguchi A, Shimokata H. Changes in serum lipid levels during a 10 year period in a large Japanese population. A cross-sectional and longitudinal study. Atherosclerosis. 2002;163:313-20. (Pubitemid 34615822)
39. Kuzuya M, Ando F, Iguchi A, Shimokata H. Age-specifi c change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis. 2007;191:305-12. (Pubitemid 46400714)
40. Abbott RD, Curb JD, Rodriguez BL, Masaki KH, Yano K, Schatz IJ, et al. Age-related changes in risk factor effects on the incidence of coronary heart disease. Ann Epidemiol. 2002;12:173-81. (Pubitemid 34189719)
41. Roades DA, Welty TK, Wang W, Yeh F, Devereux RB, Fabsitz RR, et al. Aging and the prevalence of cardiovascular risk factors in older American Indians: The strong heart study. J Am Geriatr Soc. 2007;55:87-94. (Pubitemid 46046233)
42. Anum EA, Adera T. Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis. Ann Epidemiol. 2004;14:705-21. (Pubitemid 39233631)
43. Prospective Studies Collaboration; Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007; 370:1829-39.
44. Clarke R, Emberson JR, Parish S, Palmer A, Shipley M, Linksted P, et al. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men. Arch Intern Med. 2007;167:1373-8. (Pubitemid 47052435)
45. Strandberg TE, Gylling H, Tilvis RS, Miettinen TA. Serum plant and other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men. Atherosclerosis. 2010;210:282-7.
46. Silbernagel G, Fauler G, Hoffmann MM, L ü tjohann D, Winkelmann BR, Boehm BO, et al. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. J Lipid Res. 2010;51: 2384-93.
47. Papaconstantinou J. Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination. Mol Cell Endocrinol. 2009;299:89-100.
48. Cluett C, Melzer D. Human genetic variations: Beacons on the pathways to successful ageing. Mech Ageing Dev. 2009; 130:553-63.
49. Abellan Van Kan G, Rolland Y, Bergman H, Morley JE, Kritchevsky SB, Vellas B. The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging. 2008;12:29-37. (Pubitemid 351156012)
50. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000;20:1057-60. (Pubitemid 30207582)
51. Kähönen MH, Tilvis RS, Jolkkonen J, Pitkälä K, Härkönen M. Predictors and clinical signifi cance of declining plasma dehydroepiandrosterone sulfate in old age. Aging (Milano). 20 00;12:308-14.
52. Björkman MP, Sorva AJ, Tilvis RS. Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur J Endocrinol. 2008;158:749-53. (Pubitemid 351639614)
53. Aronow WS. Management of hyperlipidemia with statins in older adults. Clin Interv Aging. 2006;1:433-8.
54. Gränsbo K, Melander O, Wallentin L, Lindbäck J, Stenestrand U, Carlsson J, et al. Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol. 2010;55: 1362-9.
55. Glynn RJ, Koenig W, Norgestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152:488-96.